CompanyGraph
SSY Group Limited
2005 · HKEX · Hong Kong
Price data from its LJUIF listing on OTC, quoted in USD
ssygroup.com.hkFinancials as of FY2025
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $558.17M, above the global median of $548.88M
- FinancialsAltman Z-Score 1.75: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
4.07%Above 5Y avg (3.91%)
Annual Rate
HKD 0.11Paid semi-annual
Payout Ratio
45.7%Sustainable
Payback Period
4.7 yr
Last Ex-Dividend
Sep 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.92BHKD1.14B · vs all stocks (USD)
Trailing P/E
15.88xRevenue (TTM)
4.38BHKD558.17M · vs all stocks (USD)
Profit Margin
11.59%Beta
0.5340xvs all stocks
52-Week Change
-7.85%vs all stocks
Forward Annual Dividend Yield
4.07%vs all stocks
Market Capitalization
8.92BHKD1.14B · vs all stocks (USD)
Enterprise Value
10.30BHKD1.31B · vs all stocks (USD)
Trailing P/E
15.88xForward P/E
10.80xPrice to Sales (TTM)
1.77xPrice to Book (MRQ)
1.00xEnterprise to Revenue
2.35xEnterprise to EBITDA
9.33xProfit Margin
11.59%Operating Margin
18.86%Return on Assets (TTM)
3.19%Return on Equity (TTM)
6.61%Revenue (TTM)
4.38BHKD558.17M · vs all stocks (USD)
Revenue per Share (TTM)
1.51HKDUpdated Sep 20, 2026Quarterly Revenue Growth
9.90%Gross Profit (TTM)
1.81BHKD231.11M · vs all stocks (USD)
EBITDA (TTM)
1.09BHKD138.74M · vs all stocks (USD)
Net Income (TTM)
507.45MHKD64.69M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
13.00%Operating Cash Flow (TTM)
635.03MHKD80.95M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
470.64MHKD59.99M · vs all stocks (USD)
Forward Annual Dividend Rate
0.1100HKDUpdated Sep 20, 2026Forward Annual Dividend Yield
4.07%vs all stocks
Trailing Annual Dividend Rate
0.0850HKDUpdated Sep 20, 2026Trailing Annual Dividend Yield
3.15%vs all stocks
5-Year Average Dividend Yield
3.91%vs all stocks
Payout Ratio
45.71%Minority Interest (Equity)
319.74MHKDFY2025 · Dec 31, 2025Revenue
4.17BHKDFY2025 · Dec 31, 2025Cost of Goods Sold
2.43BHKDFY2025 · Dec 31, 2025Gross Profit
1.73BHKDFY2025 · Dec 31, 2025Operating Income
583.88MHKD74.43M · vs all stocks (USD)
Pre-tax Income
563.70MHKDFY2025 · Dec 31, 2025Income Tax Expense
80.23MHKDFY2025 · Dec 31, 2025Net Income
483.46MHKDFY2025 · Dec 31, 2025EBIT
669.33MHKDFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.09BHKDFY2025 · Dec 31, 2025Research & Development
244.03MHKDFY2025 · Dec 31, 2025Selling, General & Administrative
774.57MHKDFY2025 · Dec 31, 2025Other Operating Expenses
-21.99MHKDFY2025 · Dec 31, 2025Non-operating Interest Income
21.12MHKDFY2025 · Dec 31, 2025Non-operating Interest Expense
105.63MHKDFY2025 · Dec 31, 2025Minority Interests (P&L)
-12.82MHKDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00HKDFY2025 · Dec 31, 2025Operating Cash Flow
654.59MHKDFY2025 · Dec 31, 2025Free Cash Flow
487.81MHKDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.69BHKDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
563.70MHKDFY2025 · Dec 31, 2025Other Non-cash Items
52.12MHKDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
27.90MHKDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
10.87MHKDFY2025 · Dec 31, 2025Capital Expenditures
-166.78MHKDFY2025 · Dec 31, 2025Net Intangibles (CF)
-163.68MHKDFY2025 · Dec 31, 2025Net Acquisitions
97.87MHKDFY2025 · Dec 31, 2025Purchase of Investments
0.00HKDFY2025 · Dec 31, 2025Sale of Investments
167.88MHKDFY2025 · Dec 31, 2025Other Investing Activity
94.48MHKDFY2025 · Dec 31, 2025Net Investing Cash Flow
193.45MHKDFY2025 · Dec 31, 2025Long-term Debt Issuance
1.48BHKDFY2025 · Dec 31, 2025Long-term Debt Payments
-1.17BHKDFY2025 · Dec 31, 2025Common Stock Repurchase
-154.45MHKDFY2025 · Dec 31, 2025Common Dividends Paid
-427.08MHKDFY2025 · Dec 31, 2025Net Financing Cash Flow
-274.84MHKDFY2025 · Dec 31, 2025Shares Outstanding
2.90BSharesUpdated Sep 20, 2026Float Shares
977.63MSharesUpdated Sep 20, 2026% Held by Insiders
66.38%vs all stocks
% Held by Institutions
14.18%vs all stocks
Total Cash (MRQ)
1.89BHKD241.00M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.6540HKDUpdated Sep 20, 2026Total Debt (MRQ)
4.05BHKD516.12M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4977xCurrent Ratio (MRQ)
1.87xBook Value per Share (MRQ)
2.70HKDUpdated Sep 20, 2026Total Assets
12.81BHKD1.63B · vs all stocks (USD)
Total Current Assets
4.96BHKDFY2025 · Dec 31, 2025Total Liabilities
5.19BHKDFY2025 · Dec 31, 2025Total Non-current Assets
7.86BHKDFY2025 · Dec 31, 2025Total Non-current Liabilities
2.57BHKDFY2025 · Dec 31, 2025Total Current Liabilities
2.62BHKDFY2025 · Dec 31, 2025Cash
1.69BHKDFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.69BHKDFY2025 · Dec 31, 2025Other Short-term Investments
46.37MHKDFY2025 · Dec 31, 2025Accounts Receivable
1.66BHKDFY2025 · Dec 31, 2025Inventory
1.20BHKDFY2025 · Dec 31, 2025Accounts Payable
281.75MHKDFY2025 · Dec 31, 2025Short-term Debt
1.77BHKDFY2025 · Dec 31, 2025Long-term Debt
2.25BHKDFY2025 · Dec 31, 2025Common Stock (Book)
65.83MHKDFY2025 · Dec 31, 2025Total Shareholders' Equity
7.62BHKD971.41M · vs all stocks (USD)
52-Week Low
2.01HKDUpdated Sep 20, 202652-Week High
3.18HKDUpdated Sep 20, 202652-Week Change
-7.85%vs all stocks
Beta
0.5340xvs all stocks
50-Day MA
2.53HKDUpdated Sep 20, 2026200-Day MA
2.58HKDUpdated Sep 20, 2026Avg 10-Day Volume
5.38MSharesUpdated Sep 20, 2026Avg 30-Day Volume
4.89MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.1700HKDUpdated Sep 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.75: grey zoneSignificant
Altman Z-Score: 1.75
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $558.17M, above the global median of $548.88MNotable
Revenue (USD): 558,172,896.691Global Median: 548,883,780.48
Levered free cash flow is $59.99M, above the global median of $18.73MNotable
Levered free cash flow (USD): 59,992,098.39Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Changchun BCHT Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Viyash Scientific Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
BioGaia AB
Tier 1ProductionApproval-Gated PipelineRuleFlow
Chongqing Taiji Industry Group Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Harbin Gloria Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hob Biotech Group Suzhou Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beta Bionics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Tianjin Ringpu Bio-Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Seegene, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Amphastar Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule